Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 106896-48-4 | MDL No. : | MFCD03844437 |
Formula : | C8H8BrNO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | NIXWZYZFLFEHMB-UHFFFAOYSA-N |
M.W : | 230.06 | Pubchem ID : | 13574117 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.12 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 49.83 |
TPSA : | 52.32 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.44 cm/s |
Log Po/w (iLOGP) : | 1.91 |
Log Po/w (XLOGP3) : | 1.78 |
Log Po/w (WLOGP) : | 1.83 |
Log Po/w (MLOGP) : | 2.06 |
Log Po/w (SILICOS-IT) : | 1.65 |
Consensus Log Po/w : | 1.85 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.63 |
Solubility : | 0.545 mg/ml ; 0.00237 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.5 |
Solubility : | 0.733 mg/ml ; 0.00318 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.97 |
Solubility : | 0.244 mg/ml ; 0.00106 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.49 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H317-H319 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | at 65℃; for 18 h; | (a) methyl 3-amino-2-bromobenzoate To a 100 mL RB flask was added 3-amino-2-bromobenzoic acid (1.75g, 8.10 mmol), concentrated H2S04 (2.159 mL, 40.5 mmol), and MeOH (80 mL). The reaction solution was heated to 65 °C for 18 h with stirring. The solvent was removed under vacuum and the residue slowly poured into iced saturated aqueous Na2C03 solution. The product was extracted from the aqueous solution with EtOAc, dried over Na2S04 and concentrated under vacuum to afford methyl 3-amino-2-bromobenzoate (1.8 g, 95percent) as a brown oil. LC-MS(ES) m/z = 230, 232 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
98% | With tin(ll) chloride In methanol; water for 2 h; Heating / reflux | 2-Bromo-3-nitro-benzoic acid methyl ester (12.9 g, 49.5 MMOL) (prepared from 2-amino-3-nitro- benzoic acid as described by Webber E. S. et AL., see patent application number WO 01/16136 A2) and SNCI2 (42 g, 223 MMOL) were REFLUXED in methanol (225 mL, 0.2 M) and H20 (5.3 G, 243 MMOL) for 2 hours. After cooling at ambient temperature, diatomaceous earth (20 G) and DICHLOROMETHANE (1 L) were added followed with 3N aqueous sodium hydroxide (150 mL) with vigorous stirring. The mixture was filtered and the organic phase was washed with saturated aqueous sodium chloride. The organic solution was dried over sodium sulfate, filtered and all volatiles were removed under reduced pressure to afford Intermediate 5 (a) (11.4 G) in 98percent yield. 1H-NMR (d6-DMSO) : o 7. 12 (dd, 1H, J = 8. 1,7. 5 Hz), 6.93 (dd, 1H, J = 8. 1,1. 6 Hz), 6.80 (dd, 1H, J = 7.4, 1.6 Hz), 5.57 (s, 2H), 3.81 (s, 3H). |
99% | With sodium hydroxide; stannous chloride In hydrogenchloride; ethanol | b)' In an alternate procedure, Methyl 2-bromo-3-aminobenzoate may be prepared as follows: A solution of stannous chloride (15.0 g, 76.1 mM) in 30 mL of concentrated hydrochloric acid was slowly added to a solution of methyl 2-bromo-3-nitrobenzoate (4.0 g, 15.4 mM) in 90 mL ethanol at 15-30 °C over 1 hour. The mixture was then heated at 50-60 °C for 15 minutes. The mixture was cooled to room temperature and made alkaline by slow addition of solid sodium hydroxide maintaining a temperature of 30-35 °C. The resultant mixture was extracted three times with chloroform. The extracts were washed with brine, dried over sodium sulfate, filtered and concentrated to afford 3.51 g (99percent) of methyl 2-bromo-3-aminobenzoate as a yellow oil, identical in all respects to the material derived via catalytic hydrogenation described above. |
99% | With sodium hydroxide; stannous chloride In hydrogenchloride; ethanol | b) Methyl 2-bromo-3-aminobenzoate A solution of stannous chloride (15.0 g, 76.1 mM) in 30 mL of concentrated hydrochloric acid was slowly added to a solution of methyl 2-bromo-3-nitrobenzoate (4.0 g, 15.4 mM) in 90 mL ethanol at 15-30° C. over 1 hour. The mixture was then heated at 50-60° C. for 15 minutes. The mixture was cooled to room temperature and made alkaline by slow addition of solid sodium hydroxide maintaining a temperature of 30-35° C. The resultant mixture was extracted three times with chloroform. The extracts were washed with brine, dried over sodium sulfate, filtered and concentrated to afford 3.51 g (99percent) of methyl 2-bromo-3-aminobenzoate as a yellow oil, identical in all respects to the material derived via catalytic hydrogenation described above. |
[ 124750-51-2 ]
5-(4'-(Bromomethyl)-[1,1'-biphenyl]-2-yl)-1-trityl-1H-tetrazole
[ 6942-37-6 ]
Methyl 5-amino-2-bromobenzoate
Similarity: 0.94
[ 98545-64-3 ]
Methyl 4-amino-2-bromobenzoate
Similarity: 0.94
[ 46064-79-3 ]
Methyl 3-amino-4-bromobenzoate
Similarity: 0.94
[ 106896-49-5 ]
Methyl 4-amino-3-bromobenzoate
Similarity: 0.94
[ 1245643-11-1 ]
Methyl 3,4-diamino-5-bromobenzoate
Similarity: 0.92
[ 6942-37-6 ]
Methyl 5-amino-2-bromobenzoate
Similarity: 0.94
[ 98545-64-3 ]
Methyl 4-amino-2-bromobenzoate
Similarity: 0.94
[ 46064-79-3 ]
Methyl 3-amino-4-bromobenzoate
Similarity: 0.94
[ 106896-49-5 ]
Methyl 4-amino-3-bromobenzoate
Similarity: 0.94
[ 1245643-11-1 ]
Methyl 3,4-diamino-5-bromobenzoate
Similarity: 0.92
[ 6942-37-6 ]
Methyl 5-amino-2-bromobenzoate
Similarity: 0.94
[ 98545-64-3 ]
Methyl 4-amino-2-bromobenzoate
Similarity: 0.94
[ 46064-79-3 ]
Methyl 3-amino-4-bromobenzoate
Similarity: 0.94
[ 106896-49-5 ]
Methyl 4-amino-3-bromobenzoate
Similarity: 0.94
[ 1245643-11-1 ]
Methyl 3,4-diamino-5-bromobenzoate
Similarity: 0.92
[ 6942-37-6 ]
Methyl 5-amino-2-bromobenzoate
Similarity: 0.94
[ 98545-64-3 ]
Methyl 4-amino-2-bromobenzoate
Similarity: 0.94
[ 46064-79-3 ]
Methyl 3-amino-4-bromobenzoate
Similarity: 0.94
[ 106896-49-5 ]
Methyl 4-amino-3-bromobenzoate
Similarity: 0.94
[ 1245643-11-1 ]
Methyl 3,4-diamino-5-bromobenzoate
Similarity: 0.92